News and Press Releases
Nxera Pharma Receives US$10m from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
27 June 2024, Tokyo, Japan and Cambridge, UK - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565), announces that it has reached an important R&D milestone under its multi-target discovery collaboration...
Category: BioManufacturing, Other, Pharmaceutical
Posted: June 28, 2024
Celonic Inaugurates “Next Generation” Biologics Development Centre (BDC) and Pilot Plant in Basel, Switzerland
The Celonic Group, a “Pure Play” Biologics contract development and manufacturing organisation (CDMO), expands process development and optimisation services in Basel Investment builds on “Next Generation” bioprocessing capability and pilot...
Category: BioManufacturing, Pharmaceutical
Posted: June 18, 2024
Freudenberg Medical Expands Coatings Business with New Production Facility
Investment of more than $50m to meet growing global demand for drug and hydrophilic coatings for medical devices and components Manufacturing footprint tripled with new 130,000sqft facility in the Aachen...
Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: June 11, 2024
Oxford Drug Design and CRUK Scotland Institute awarded MRC grant funding to advance novel cancer therapeutics discovery
Collaboration to use genetically engineered mouse models to validate a new approach to cancer therapy 4 June 2024 - United Kingdom - The CRUK (Cancer Research UK) Scotland Institute and Oxford...
Category: Drug Discovery
Posted: June 10, 2024
Oxford Drug Design Lt,d Oxford Centre for Innovation, New Road, Oxford, OX1 1BY, UK
Vetter announces plans to expand its capacity in the US and Germany
Leading globally operating CDMO outlines location and design of new manufacturing sites to meet increasing customer demands Vetter Advisory Board decides on strategic path forward for further independent and sustainable...
Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: June 6, 2024
Bionova Scientific announces plans for new Plasmid DNA GMP facility
Facility in The Woodlands, Texas, US, to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025 3 June 2024 -- California, US --...
Category: BioManufacturing, Manufacturing and Packing, Pharmaceutical
Posted: June 3, 2024
Ardena appoints Jeremie Trochu as Chief Executive Officer
3 June 2024 -- Ghent, Belgium -- Ardena today announces the retirement of Harry Christiaens PhD, and the subsequent appointment of Jeremie Trochu as chief executive officer. Jeremie is a...
Category: BioManufacturing, Biotechnology, Logistics, Manufacturing and Packing, Pharmaceutical
Posted: June 3, 2024
Asymchem welcomes Franck Mevellec as senior director of Business Development
29 May 2024 -- Paris, France -- Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director of business development. Franck brings over...
Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 29, 2024
Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China
Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site
6 May 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today announced its investment in a second manufacturing line for...
Category: Drug Delivery, Manufacturing and Packing
Posted: May 6, 2024
Owlstone Medical Secures $6.5m to Support Development of Breath-based Diagnostics for Infectious Disease
$5m equity investment and initial $1.5m grant funding committed by the Bill & Melinda Gates Foundation for development of breath-based diagnostic solutions to improve outcomes in the developing world Funding...
Category: Biotechnology, Other
Posted: April 25, 2024
Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study
The UK’s Medical Research Council is funding a 10-patient phase 1 study to deliver rapid personalised treatment for lung cancer patients 3 April 2024 -- Hampton, UK -- Touchlight, a...
Category: Biotechnology, Clinical Trials
Posted: April 3, 2024
Touchlight Awarded Tender to Supply Enzymatic dbDNA to CPI’s RNA Centre of Excellence
28 March 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO enabling the development of genetic medicines with its doggybone DNA (dbDNA) technology and leaders in enzymatic DNA production, is...
Category: Biotechnology
Posted: March 28, 2024
Recipharm attains major sustainability milestones
Approval of ambitious Greenhouse Gas emission reduction targets by SBTi Commitment to renewable electricity sourcing to 100.0% by 2024 and to 42.1% GHG emission reduction (Scope 1 and 2) by...
Category: Manufacturing and Packing
Posted: March 26, 2024
Gilbert To Officially Open New Development and GMP Manufacturing Facility
22 March 2024 -- Nottingham, UK -- UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and...
Category: BioManufacturing, Clinical Trials, Manufacturing and Packing
Posted: March 22, 2024
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN
Eisbach and Cancer Focus Fund Announce $4.5m Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumours
Eisbach is enabling the potential of synthetic lethality by developing novel compounds to exploit molecular vulnerabilities uniquely present in many hard-to-treat cancers 21 March 2024 -- Martinsried, Germany and Texas, US...
Category: Biotechnology, Pharmaceutical
Posted: March 21, 2024
